Daphne Zohar insider trades

Open-market stock purchases and sales by Daphne Zohar, Chief Executive Officer at Seaport Therapeutics, Inc, from SEC Form 4 filings since Apr 30, 2026.

Recent trades

DateStockTradeValue
Apr 30, 2026SPTX Seaport Therapeutics, IncBought (not open market)—
Apr 30, 2026SPTX Seaport Therapeutics, IncBought (not open market)—

Companies traded

  • SPTX Seaport Therapeutics, Inc: other filings, last Apr 30, 2026

Get free alerts when Daphne Zohar files a new trade →